Purple Biotech (PPBT) Pension (2015 - 2026)
Purple Biotech (PPBT) reported Pension of $160000.0 for Q1 2026, little changed on a QoQ basis from $160000.0 in Q4 2025.
Purple Biotech (PPBT) has 11 years of Pension data on file, last reported at $160000.0 in Q1 2026.
- Quarterly Pension changed N/A year-over-year to $160000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $160000.0 (changed N/A YoY) and the FY2025 annual result came in at $160000.0, up 14.29% from the prior year.
- Pension was little changed at $160000.0 in Q1 2026 per PPBT's latest filing, from $160000.0 in the prior quarter.
- Across five years, Pension topped out at $160000.0 in Q4 2025 and bottomed at $140000.0 in Q4 2024.
- The 5-year median for Pension is $145000.0 (2022), against an average of $149200.0.
- The widest annual swing landed in 2022, when Pension tumbled 50.34%; it then advanced 14.29% in 2025.
- Tracing PPBT's Pension over 5 years: stood at $145000.0 in 2022, then slipped by 2.76% to $141000.0 in 2023, then declined by 0.71% to $140000.0 in 2024, then advanced by 14.29% to $160000.0 in 2025, then changed by 0.0% to $160000.0 in 2026.
- Per Business Quant, the three latest PPBT Pension figures stand at $160000.0 (Q1 2026), $160000.0 (Q4 2025), and $140000.0 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 160,000.00 |
| Dec 31, 2025 | 160,000.00 |
| Sep 30, 2025 | 140,000.00 |
| Jun 30, 2025 | 140,000.00 |
| Mar 31, 2025 | 140,000.00 |
| Dec 31, 2024 | 140,000.00 |
| Sep 30, 2024 | 141,000.00 |
| Jun 30, 2024 | 141,000.00 |
| Mar 31, 2024 | 141,000.00 |
| Dec 31, 2023 | 141,000.00 |
| Sep 30, 2023 | 141,000.00 |
| Jun 30, 2023 | 141,000.00 |
| Mar 31, 2023 | 141,000.00 |
| Dec 31, 2022 | 145,000.00 |
| Sep 30, 2022 | 144,000.00 |
| Jun 30, 2022 | 292,000.00 |
| Mar 31, 2022 | 292,000.00 |
| Dec 31, 2021 | 292,000.00 |
| Sep 30, 2021 | 265,000.00 |
| Jun 30, 2021 | 265,000.00 |
| Mar 31, 2021 | 265,000.00 |
| Dec 31, 2020 | 265,000.00 |
| Jun 30, 2020 | 246,000.00 |
| Dec 31, 2019 | 285,000.00 |
| Jun 30, 2019 | 256,000.00 |
| Dec 31, 2018 | 405,000.00 |
| Jun 30, 2018 | 470,000.00 |
| Dec 31, 2017 | 492,000.00 |
| Jun 30, 2017 | 440,000.00 |
| Dec 31, 2016 | 256,000.00 |
| Jun 30, 2016 | 186,000.00 |
| Dec 31, 2015 | 185,000.00 |